Urine concentrations of fentanyl and norfentanyl during application of Duragesic® transdermal patches

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 422-425

  Poklis, Alphonse ^a   Backer, Ronald ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ameritox Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS DERIVATIVE; COCAINE DERIVATIVE; CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OXYCODONE;

CONFERENCE PAPER; DRUG DETERMINATION; DRUG METABOLISM; DRUG SCREENING; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; SUSTAINED DRUG RELEASE; TRANSDERMAL PATCH;

CANNABIS; CANNABIS SATIVA;

EID: 4344686674     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.422     Document Type: Conference Paper

References (12)

1. A. Poklis. Fentanyl: a review for clinical and analytical toxicologists. J. Toxicol. Clin. Toxicol. 33: 439 (1995).
2. B.E. Marshall and H. Wollman. General anesthetics. In Goodman and Gilman's Pharmacological Basis of Therapeutics, 7th ed., A.C. Gilman, L.S. Goodman, T.W. Rail, and F. Murad, Eds. MacMillian, New York, NY, 1985, p 517.
3. Physicians' Desk Reference, 48th ed. Medical Economics Co., Montvale, NJ, 1994, pp 1092-1093.
4. K.A. Calis, D.R. Kohler, and D.M. Corso. Transdermally administered fentanyl for pain management. Clin. Pharm. 11: 22-36 (1980).
5. D.A. McClain and J.C. Hug. Intravenous fentanyl kinetics. Clin. Pharmacol. Ther. 28: 106-114 (1980).
6. P. Hess, G. Steibler, and A. Herz. Pharmacokinetics of fentanyl in man and rabbit, Eur. J. Clin. Pharmacol. 4: 137-141 (1972).
7. Y. Maruyama and E. Hosoya. Studies on the fate of fentanyl. Keio. J. Med. 18: 50-70 (1979).
8. A. Rafii, D.L. Haller, and A. Poklis. Incidence of recreational drug use among chronic pain clinic patients. Abstract. American Pain Society Annual Meeting, St. Louis, MO. October 15, 1990.
9. R.C. Baselt. Disposition of Toxic Drug and Chemicals in Man, 6th ed. Chemical Toxicology Institute, Foster City, CA. 2003, pp 319-322.
10. J.C. Schwartz, J.C. Garriott, J.S. Somerset, E.J. Igler, R. Rodriguez, and M.D. Orr. Measurements of fentanyl and sufentanil in blood and urine after surgical application. Implications in detection of abuse. Am. J. Forensic Med. Pathol. 15: 236-241 (1994).
11. D.T. Anderson and J.J. Muto. Duragesic® transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J. Anal. Toxicol. 24: 627-631 (2000).
12. H. Stoeckel, J.H. Hengstmann, and J. Schuttler. Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. Brit. J. Anesthiol. 51: 741-745 (1979).